Brain natriuretic peptide predicts functional outcome in ischemic stroke

Stroke

Volumn 43, Issue 2, 2012, Pages 441-445

  Rost, Natalia S ^a   Biffi, Alessandro ^a   Cloonan, Lisa ^a   Chorba, John ^d   Kelly, Peter ^b   Greer, David ^c   Ellinor, Patrick ^a   Furie, Karen L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c YALE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute stroke; biomarkers; brain infarction; heart brain; outcomes

Indexed keywords

ANTITHROMBOCYTIC AGENT; BRAIN NATRIURETIC PEPTIDE; WARFARIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; EMERGENCY CARE; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART EJECTION FRACTION; HEART STROKE VOLUME; HOLTER MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; BRAIN; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; STROKE; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84856466752     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.629212     Document Type: Article

References (43)

1. Hankey G. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis. 2003;16:14-19. (Pubitemid 36438779)
2. Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CMM, Ratnasabapathy Y, Glen E; ASTRO study group. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke. Neurology. 2010;75:1597-1607.
3. Weimar C, Ziegler A, König IR, Diener H-C. Predicting functional outcome and survival after acute ischemic stroke. J Neurol. 2002;249:888.
4. Baird AE, Dambrosia J, Janket S-J, Eichbaum Q, Chaves C, Silver B, et al. A three-item scale for the early prediction of stroke recovery. Lancet. 2001;357:2095.
5. Johnston KC, Connors AF Jr, Wagner DP, Haley EC Jr. Predicting outcome in ischemic stroke: external validation of predictive risk models. Stroke. 2003;34:200-202. (Pubitemid 36070822)
6. German Stroke Study C. Predicting outcome after acute ischemic stroke. Neurology. 2004;62:581-585.
7. Roth DL, Haley WE, Clay OJ, Perkins M, Grant JS, Rhodes JD, et al. Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers. Stroke. STROKEAHA. 2011;42: 626-631.
8. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: A systematic review. Stroke. 2009;40: e380-389.
9. Elkind M, Tai W, Coates K, Paik MC, Sacco RL. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med. 2006;166:2073-2080. (Pubitemid 44631394)
10. Heuschmann PU, Wiedmann S, Wellwood I, Rudd A, Di Carlo A, Bejot Y, et al. Three-month stroke outcome. Neurology. 2011;76:159-165.
11. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-839.
12. Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, et al; for the PITTI Concentrations of c-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clin Chem. 2009;55:265-273.
13. Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. nt-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients. Eur J Intern Med. 2007;18:215.
14. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121:200-207.
15. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008;39:2280-2287.
16. Naya T, Hosomi N, Takahashi T, Ohkita H, Mukai M, Koziol JA, et al. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation. Cerebrovasc Dis. 2008;26:434-440.
17. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32:2559-2566. (Pubitemid 33055306)
18. Shibazaki K, Iguchi Y, Aoki J, Sakai K, Kobayashi K. Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation. Eur J Neurol. 2011;18:165-169.
19. Etgen T, Baum H, Sander K, Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke. 2005;36:270-275. (Pubitemid 40170807)
20. Idris I, Hill R, Ross I, Sharma JC. N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. Age Ageing. 2010;39:752-755.
21. Kelly PJ, Kistler JP, Shih VE, Mandell R, Atassi N, Barron M, et al. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke. 2004;35:12-15. (Pubitemid 38057581)
22. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke. 2010;41:437-442.
23. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
24. Ellinor PT, Low AF, Patton KK, Shea MA, MacRae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol. 2005;45:82.
25. Bassan R, Tura BR, Maisel AS. B-type natriuretic peptide: A strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department. Coron Artery Dis. 2009;20:143-149.
26. Peacock W. Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making. Rev Cardiovasc Med. 2010;11:S45-50.
27. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke. 1990;21:4-13. (Pubitemid 20052524)
28. Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36:916-923.
29. Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke. 1993;24:26-30. (Pubitemid 23014377)
30. Ng YS, Stein J, Ning M, Black-Schaffer RM. Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke. 2007;38:2309-2314. (Pubitemid 47457574)
31. Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005;33:2094-2013.
32. Troughton RW, Frampton CM, Yandle TG, Espine EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-BNP) concentrations. Lancet. 2000;355:1126.
33. Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007;116:249-257. (Pubitemid 47196560)
34. Hankey GJ, Spiesser J, Hakimi Z, Bego G, Carita P, Gabriel S. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology. 2007;68:1583-1587. (Pubitemid 46717982)
35. Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, et al. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke. 2009;40:2805-2811.
36. Silva G, Lima FO, Camargo E, Smith WS, Lev MH, Harris GJ, et al. Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis. 2010;30:470-475.
37. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, et al; for the S-MI Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Stroke. 2008;39:3316-3322.
38. Koton S, Green M, Bornstein N. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first National Acute Stroke Israeli Survey (NASIS 2004). Neuroepidemiology. 2010;34:90-96.
39. Clark PC, Dunbar SB, Shields CG, Viswanathan B, Aycock DM, Wolf SL. Influence of stroke survivor characteristics and family conflict surrounding recovery on caregivers' mental and physical health. Nurs Res. 2004;53:406-413. (Pubitemid 40090949)
40. Ay H, Benner T, Murat Arsava E, Furie KL, Singhal AB, Jensen MB, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007;38: 2979-2984. (Pubitemid 350035693)
41. Menezes NM, Ay H, Wang Zhu, Lopez CJ, Singhal AB, Karonen JO, et al. The real estate factor. Stroke. 2007;38:194-197.
42. Saritas A, Cakir Z, Emet M, Uzkeser M, Akoz A, Acemoglu H. Factors affecting the B-type natriuretic peptide levels in stroke patients. Ann Acad Med Singapore. 2010;39:385-389.
43. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, et al; on behalf of the American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk. Circulation. 2009;119:2408-2416.